San Diego Company’s Stem Cells Treat Diabetes in Mice
The San Diego Union-Tribune “A tiny San Diego biotechnology company has coaxed human embryonic stem cells to evolve into...The San Diego Union-Tribune
“A tiny San Diego biotechnology company has coaxed human embryonic stem cells to evolve into cells that produce insulin to control blood sugar when injected into mice with diabetes, according to a study published online Wednesday in the journal Nature Biotechnology.”
Read more »